KTTA
Pasithea Therapeutics Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.82
-0.01 ▼ -0.88%
🌙 3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.82
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -5.08 | Insider Own | 12.28% | Shs Outstand | 0.02B | Perf Week | 2.95% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | -20.59% | Insider Trans | 7.59% | Shs Float | 0.02B | Perf Month | 11.26% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 53.44% | Short Float | 0.86% | Perf Quarter | -29.31% |
| Income | -0.01B | P/S | - | EPS this Y | 54.67% | Inst Trans | 37.77% | Short Ratio | 0.73 | Perf Half Y | 3.93% |
| Sales | 0.00B | P/B | 0.5 | EPS next 5Y | 16.6% | ROA | -83.64% | Short Interest | 0.17M | Perf YTD | -36.43% |
| Book/sh | 1.64 | P/C | 4.49 | EPS past 3/5Y | -88.65% -282.28% | ROE | -89.9% | 52W High | -78.36% ($3.79) | Perf Year | -21.15% |
| Cash/sh | 0.18 | P/FCF | - | Sales past 3/5Y | - | ROIC | -110.55% | 52W Low | 191.81% ($0.28) | Perf 3Y | -90.89% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 66.41% | Gross Margin | - | Volatility(W/M) | 6.84% 8.81% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.02 | EPS Q/Q | 85.8% | Profit Margin | - | RSI (14) | 49.57 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.02 | Sales Q/Q | - | SMA20 | 1.86% ($0.81) | Beta | 0.2 | Target Price | $3 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | -4.47% ($0.86) | Rel Volume | 0.22 | Prev Close | $0.83 |
| Employees | 4 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 0.17% ($0.82) | Avg Volume(3M) | 0.24M | Price | $0.82 |
| IPO | 2021/9/15 | Option/Short | No/Yes | Trades | 147 | Volume | 51,525 | Change | -0.88% |
뉴스 로딩 중...